Mesa Labs Acquires Sterilization Process Control Business

October 5, 2017, Lakewood, Colorado – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced the acquisition of all of the outstanding shares of SIMICON GMBH (“SIMICON”), located in greater Munich, Germany. SIMICON manufactures both cleaning and biological indicators, which will be integrated into Mesa’s Biological Indicators Division. The acquisition is expected…

Mesa Labs Declares Quarterly Dividend

October 3, 2017, Lakewood, Colorado – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 15, 2017, to shareholders of record at the close of business on…

Mesa Labs Declares Quarterly Dividend

Lakewood, Colorado, July 5, 2017 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15, 2017, to shareholders of record at the close of business…

Mesa Labs

Mesa Labs Reports Record First Quarter Revenues

Lakewood, Colorado, July 31, 2017 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record revenues for the first quarter ended June 30, 2017. Revenues for the first quarter increased seven percent to $22,673,000 as compared to $21,114,000 for the same quarter last year. Operating income for the first quarter…

Mesa Labs Reports Net Income and Adjusted Net Income

Lakewood, Colorado, June 7, 2017 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record net income and adjusted net income for the year ended March 31, 2017. Highlights for the year ended March 31, 2017 as compared to last year: Revenues increased 11 percent Non-GAAP adjusted net income1 increased…

Mesa Labs Declares Quarterly Dividend

Lakewood, Colorado, April 5, 2017 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 15, 2017, to shareholders of record at the close of business…

Mesa Labs Declares Quarterly Dividend

Lakewood, Colorado, January 3, 2017 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 15, 2017, to shareholders of record at the close of business…

Specialty Pharmacy Solutions

Applying Specialty Pharmacy Regulations When Working with Partners or Contracted Organizations

Partner models consist of a healthcare institution operating a specialty pharmacy in partnership or in contract with another entity to offer the full range of services required for an accredited specialty pharmacy. Accreditation standards are a valuable resource to healthcare pharmacy leaders to ensure that all internal and partner specific regulatory components are in place.…